| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 70,3 M € | +9.8% | 64,0 M € | +0.4% | 63,7 M € | +3.6% | 61,6 M € | +12.4% | 54,8 M € | +3.1% | 53,1 M € | +9.1% | 48,7 M € | +245.1% | 14,1 M € | -3.1% | 14,6 M € | +17.2% | 12,4 M € | +4.6% | 11,9 M € | -7.9% | 12,9 M € | -2.0% | 13,2 M € | -3.1% | 13,6 M € | |
| EBITDA | 3,9 M € | -20.0% | 4,9 M € | +78.8% | 2,7 M € | -38.5% | 4,4 M € | +126.2% | 2,0 M € | -23.0% | 2,5 M € | -28.4% | 3,6 M € | +287.8% | 918,3 k € | -7.2% | 989,4 k € | +7.0% | 924,4 k € | +36.9% | 675,0 k € | +19.5% | 564,7 k € | -34.2% | 857,7 k € | +61.8% | 530,0 k € | |
| Operating profit | 3,7 M € | -9.9% | 4,2 M € | +57.5% | 2,6 M € | -37.7% | 4,2 M € | +179.5% | 1,5 M € | -27.7% | 2,1 M € | -27.3% | 2,9 M € | +345.8% | 646,4 k € | -10.9% | 725,8 k € | +2.2% | 710,4 k € | +50.9% | 470,9 k € | +39.1% | 338,6 k € | -24.4% | 448,1 k € | +304.6% | 110,8 k € | |
| Profit/loss | 2,2 M € | -31.6% | 3,2 M € | +88.7% | 1,7 M € | -43.1% | 3,0 M € | +231.5% | 899,4 k € | -51.3% | 1,8 M € | -29.5% | 2,6 M € | +813.8% | 286,4 k € | +83.6% | 156,0 k € | -96.4% | 4,4 M € | +1644.4% | 250,2 k € | -8.0% | 272,0 k € | -30.4% | 390,6 k € | +110.0% | 186,0 k € | |
| Equity | 30,5 M € | +7.8% | 28,3 M € | +12.8% | 25,1 M € | +7.3% | 23,4 M € | +14.6% | 20,4 M € | +28.2% | 15,9 M € | +13.1% | 14,1 M € | +94.0% | 7,2 M € | +4.1% | 7,0 M € | +2.3% | 6,8 M € | +32.4% | 5,1 M € | +5.1% | 4,9 M € | +5.9% | 4,6 M € | +9.2% | 4,2 M € | |
| Total assets | 38,8 M € | +5.5% | 36,8 M € | +4.8% | 35,1 M € | +8.6% | 32,3 M € | +12.1% | 28,9 M € | +9.0% | 26,5 M € | +1.2% | 26,2 M € | +125.2% | 11,6 M € | -2.6% | 11,9 M € | -16.4% | 14,3 M € | +12.6% | 12,7 M € | +71.9% | 7,4 M € | +5.7% | 7,0 M € | -2.3% | 7,1 M € | |
| Cash | 1,1 M € | -92.1% | 13,9 M € | +16.0% | 12,0 M € | +207.2% | 3,9 M € | -49.1% | 7,7 M € | -14.7% | 9,0 M € | +106093.0% | 8,5 k € | -99.9% | 8,6 M € | +2.0% | 8,5 M € | +13.7% | 7,5 M € | +10075.9% | 73,3 k € | -96.4% | 2,0 M € | +6.0% | 1,9 M € | +304.2% | 470,8 k € | |
| Debts | 6,9 M € | +2.8% | 6,7 M € | -20.1% | 8,4 M € | +13.1% | 7,4 M € | +3.0% | 7,2 M € | -16.0% | 8,6 M € | -12.6% | 9,8 M € | +173.1% | 3,6 M € | -12.1% | 4,1 M € | -41.5% | 7,0 M € | +6.8% | 6,6 M € | +291.1% | 1,7 M € | +24.0% | 1,4 M € | -30.6% | 2,0 M € | |
| Staff | 29,2 | 31,5 | 33,8 | 33,8 | 32,5 | 37,1 | 43,3 | 32,7 | 32,6 | 33,1 | 23,4 | 22,4 | 22,2 | 22,3 | ||||||||||||||
Public limited company · Zaventem · incorporated on 01/01/1968 · 29,2 ETP
Public limited company profitable and well capitalised. Cash position declining (-92.1%).
Solid counterparty for a standard engagement.
LIVANOVA BELGIUM is a Public limited company incorporated in 1968. Its main activity is: Commerce de gros de produits pharmaceutiques et médicaux. Its registered office is in Zaventem. It employs on average 29,2 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette